Mads S. Toustrup-Jensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mads S. Toustrup-Jensen has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Bente Vilsen
Department of Biomedicine, Aarhus University, DK-8000 Aarhus, Denmark
21 shared publications - Jens Peter Andersen
Department of Biomedicine, Aarhus University, DK-8000 Aarhus, Denmark
11 shared publications Rikke Holm
From the Department of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark and
5 shared publications- Jens Preben Morth
Technical University of Denmark
4 shared publications - Poul Nissen
DANDRITE, Nordic EMBL Partnership for Molecular Medicine, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark
4 shared publications Anja Pernille Einholm
Centre for Membrane Pumps in Cells and Disease-PUMPKIN, Danish National Research Foundation, Department of Physiology and Biophysics, Aarhus University, DK-8000 Aarhus C, Denmark
3 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (18) , 8424
Mechanism of Rescue of Na+,K+-ATPase Function in Neurological Disease Revealed by New Super-Efficient Second-Site Mutations
Serious neurological disorders are caused by mutation of Na+,K+-ATPase α1–α3 isoforms. Several disease mutations reduce the affinity for Na+, which in vivo results in an increase in the intracellular Na+ concentration with a secondary rise in intracellular Ca2+. Current treatments are ineffective, as they do not address Na+,K+-ATPase function. Hence, a platform for the development of a rational therapeutic approach that restores Na+ affinity is needed. Using the COS-1 cell expression system, one of the most conspicuous reductions in Na+ affinity of Na+,K+-ATPase has been reported for the neurological disease mutation α3-D923N of the α3 isoform. We describe here second-site mutations (“rescue mutations”) that fully restore Na+ affinity of α3-D923N and the corresponding rat α1-D928N and reveal the underlying molecular mechanism. Paradoxically, this insight evolved from investigation of a rapid-onset ataxia Na+,K+-ATPase mutant, α3-G316S, that exhibits an increased affinity for Na+. When applied as second-site mutations, α3-G316S and the corresponding rat α1-G321S are super-efficient rescuers of the reduced Na+ affinity of α3-D923N and rat α1-D928N. Replacement of the glycine with serine leads to a clash between transmembrane helices in the K+-bound E2 state of Na+,K+-ATPase but not in the Na+-bound E1 state. A similarly strong rescuing power is observed for second-site mutations breaking a salt bridge present only in the E2 state. The rescue is due to a structural change resembling the rearrangement of the ion binding sites occurring during the normal Na+,K+-ATPase transport cycle as part of the E2-to-E1 conformational transition.
- 21 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (18) , 8424
Open AccessMechanism of Rescue of Na+,K+-ATPase Function in Neurological Disease Revealed by New Super-Efficient Second-Site Mutations
Serious neurological disorders are caused by mutation of Na+,K+-ATPase α1–α3 isoforms. Several disease mutations reduce the affinity for Na+, which in vivo results in an increase in the intracellular Na+ concentration with a secondary rise in intracellular Ca2+. Current treatments are ineffective, as they do not address Na+,K+-ATPase function. Hence, a platform for the development of a rational therapeutic approach that restores Na+ affinity is needed. Using the COS-1 cell expression system, one of the most conspicuous reductions in Na+ affinity of Na+,K+-ATPase has been reported for the neurological disease mutation α3-D923N of the α3 isoform. We describe here second-site mutations (“rescue mutations”) that fully restore Na+ affinity of α3-D923N and the corresponding rat α1-D928N and reveal the underlying molecular mechanism. Paradoxically, this insight evolved from investigation of a rapid-onset ataxia Na+,K+-ATPase mutant, α3-G316S, that exhibits an increased affinity for Na+. When applied as second-site mutations, α3-G316S and the corresponding rat α1-G321S are super-efficient rescuers of the reduced Na+ affinity of α3-D923N and rat α1-D928N. Replacement of the glycine with serine leads to a clash between transmembrane helices in the K+-bound E2 state of Na+,K+-ATPase but not in the Na+-bound E1 state. A similarly strong rescuing power is observed for second-site mutations breaking a salt bridge present only in the E2 state. The rescue is due to a structural change resembling the rearrangement of the ion binding sites occurring during the normal Na+,K+-ATPase transport cycle as part of the E2-to-E1 conformational transition.
- Open Access
- 17 April 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (4) , 601
A Highly Conserved Glycine in a Hotspot for Neurological Disease Mutations in Na+,K+-ATPase Is Critical to Na+ and K+ Occlusion
Na+,K+-ATPase possesses a highly conserved glycine (G358 in the α3 isoform) that—together with a nearby isoleucine (I363 in α3)—is targeted by mutations causing some of the most severe neurological phenotypes of the clinical spectrum of α3-Na+,K+-ATPase mutations. The disease mutations α3-G358V and α3-I363N affect Na+ and K+ transport to an extent incompatible with cell growth. However, alanine replacement of the corresponding glycine G363 in the α1 isoform is compatible with cell growth, allowing the effects on Na+,K+-ATPase function to be addressed using enzymatic assays on plasma membranes isolated from transfected cells. Occlusion of Na+ appears to be defective in mutant G363A, resulting in a reduced rate of phosphorylation from ATP. Furthermore, the mutation displaces the major conformational equilibrium of Na+,K+-ATPase such that the K+-occluded state is destabilized and occluded K+ is released faster, thereby leading to accumulation of a non-productive state without bound Na+ or K+. The critical function of the glycine can be ascribed to a strategic location at the bending point between an α helix and a β strand, where it connects the catalytic ATP hydrolysis site in the cytoplasmic P domain with the ion-binding region in the membrane and coordinates important intramolecular domain movements during the Na+,K+-ATPase transport cycle.
- 17 April 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (4) , 601
Open AccessA Highly Conserved Glycine in a Hotspot for Neurological Disease Mutations in Na+,K+-ATPase Is Critical to Na+ and K+ Occlusion
Na+,K+-ATPase possesses a highly conserved glycine (G358 in the α3 isoform) that—together with a nearby isoleucine (I363 in α3)—is targeted by mutations causing some of the most severe neurological phenotypes of the clinical spectrum of α3-Na+,K+-ATPase mutations. The disease mutations α3-G358V and α3-I363N affect Na+ and K+ transport to an extent incompatible with cell growth. However, alanine replacement of the corresponding glycine G363 in the α1 isoform is compatible with cell growth, allowing the effects on Na+,K+-ATPase function to be addressed using enzymatic assays on plasma membranes isolated from transfected cells. Occlusion of Na+ appears to be defective in mutant G363A, resulting in a reduced rate of phosphorylation from ATP. Furthermore, the mutation displaces the major conformational equilibrium of Na+,K+-ATPase such that the K+-occluded state is destabilized and occluded K+ is released faster, thereby leading to accumulation of a non-productive state without bound Na+ or K+. The critical function of the glycine can be ascribed to a strategic location at the bending point between an α helix and a β strand, where it connects the catalytic ATP hydrolysis site in the cytoplasmic P domain with the ion-binding region in the membrane and coordinates important intramolecular domain movements during the Na+,K+-ATPase transport cycle.
- Open Access
- 1 January 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (1) , 269-280
Functional consequences of the CAPOS mutation E818K of Na+,K+-ATPase
- 1 January 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (1) , 269-280
Open AccessFunctional consequences of the CAPOS mutation E818K of Na+,K+-ATPase
- 1 November 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1857 (11) , 1807-1828
Neurological disease mutations of α3 Na+,K+-ATPase: Structural and functional perspectives and rescue of compromised function
- 1 November 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1857 (11) , 1807-1828
Neurological disease mutations of α3 Na+,K+-ATPase: Structural and functional perspectives and rescue of compromised function
- Open Access
- 1 May 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (20) , 10934-10947
Importance of a Potential Protein Kinase A Phosphorylation Site of Na+,K+-ATPase and Its Interaction Network for Na+ Binding
- 1 May 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (20) , 10934-10947
Open AccessImportance of a Potential Protein Kinase A Phosphorylation Site of Na+,K+-ATPase and Its Interaction Network for Na+ Binding
- Open Access
- 1 February 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (6) , 3186-3197
Relationship between Intracellular Na+ Concentration and Reduced Na+ Affinity in Na+,K+-ATPase Mutants Causing Neurological Disease
- 1 February 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (6) , 3186-3197
Open AccessRelationship between Intracellular Na+ Concentration and Reduced Na+ Affinity in Na+,K+-ATPase Mutants Causing Neurological Disease
- Open Access
- 1 August 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (34) , 26245-26254
The Rapid-onset Dystonia Parkinsonism Mutation D923N of the Na+,K+-ATPase α3 Isoform Disrupts Na+ Interaction at the Third Na+ Site
- 1 August 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (34) , 26245-26254
Open AccessThe Rapid-onset Dystonia Parkinsonism Mutation D923N of the Na+,K+-ATPase α3 Isoform Disrupts Na+ Interaction at the Third Na+ Site
- Open Access
- 1 July 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (28) , 18715-18725
The C Terminus of Na+,K+-ATPase Controls Na+ Affinity on Both Sides of the Membrane through Arg935
- 1 July 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (28) , 18715-18725
Open AccessThe C Terminus of Na+,K+-ATPase Controls Na+ Affinity on Both Sides of the Membrane through Arg935
- Open Access
- 7 April 2009
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 18 (13) , 2370-2377
A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism
The Na+/K+-ATPases are ion pumps of fundamental importance in maintaining the electrochemical gradient essential for neuronal survival and function. Mutations in ATP1A3 encoding the α3 isoform cause rapid-onset dystonia-parkinsonism (RDP). We report a de novo ATP1A3 mutation in a patient with typical RDP, consisting of an in-frame insertion of a tyrosine residue at the very C terminus of the Na+/K+-ATPase α3-subunit—the first reported RDP mutation in the C terminus of the protein. Expression studies revealed that there is no defect in the biogenesis or plasma membrane targeting, although cells expressing the mutant protein showed decreased survival in response to ouabain challenge. Functional analysis demonstrated a drastic reduction in Na+ affinity in the mutant, which can be understood by structural modelling of the E1 and E2 conformations of the wild-type and mutant enzymes on the basis of the strategic location of the C terminus in relation to the third Na+ binding site. The dramatic clinical presentation, together with the biochemical findings, provides both in vivo and in vitro evidence for a crucial role of the C terminus of the α-subunit in the function of the Na+/K+-ATPase and a key impact of Na+ affinity in the pathophysiology of RDP.
- 7 April 2009
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 18 (13) , 2370-2377
Open AccessA C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism
The Na+/K+-ATPases are ion pumps of fundamental importance in maintaining the electrochemical gradient essential for neuronal survival and function. Mutations in ATP1A3 encoding the α3 isoform cause rapid-onset dystonia-parkinsonism (RDP). We report a de novo ATP1A3 mutation in a patient with typical RDP, consisting of an in-frame insertion of a tyrosine residue at the very C terminus of the Na+/K+-ATPase α3-subunit—the first reported RDP mutation in the C terminus of the protein. Expression studies revealed that there is no defect in the biogenesis or plasma membrane targeting, although cells expressing the mutant protein showed decreased survival in response to ouabain challenge. Functional analysis demonstrated a drastic reduction in Na+ affinity in the mutant, which can be understood by structural modelling of the E1 and E2 conformations of the wild-type and mutant enzymes on the basis of the strategic location of the C terminus in relation to the third Na+ binding site. The dramatic clinical presentation, together with the biochemical findings, provides both in vivo and in vitro evidence for a crucial role of the C terminus of the α-subunit in the function of the Na+/K+-ATPase and a key impact of Na+ affinity in the pathophysiology of RDP.
- 28 October 2008
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 364 (1514) , 217-227
The structure of the Na + ,K + -ATPase and mapping of isoform differences and disease-related mutations
The Na + ,K + -ATPase transforms the energy of ATP to the maintenance of steep electrochemical gradients for sodium and potassium across the plasma membrane. This activity is tissue specific, in particular due to variations in the expressions of the alpha subunit isoforms one through four. Several mutations in alpha2 and 3 have been identified that link the specific function of the Na + ,K + -ATPase to the pathophysiology of neurological diseases such as rapid-onset dystonia parkinsonism and familial hemiplegic migraine type 2. We show a mapping of the isoform differences and the disease-related mutations on the recently determined crystal structure of the pig renal Na + ,K + -ATPase and a structural comparison to Ca 2+ -ATPase. Furthermore, we present new experimental data that address the role of a stretch of three conserved arginines near the C-terminus of the alpha subunit (Arg1003–Arg1005).
- 28 October 2008
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 364 (1514) , 217-227
The structure of the Na + ,K + -ATPase and mapping of isoform differences and disease-related mutations
The Na + ,K + -ATPase transforms the energy of ATP to the maintenance of steep electrochemical gradients for sodium and potassium across the plasma membrane. This activity is tissue specific, in particular due to variations in the expressions of the alpha subunit isoforms one through four. Several mutations in alpha2 and 3 have been identified that link the specific function of the Na + ,K + -ATPase to the pathophysiology of neurological diseases such as rapid-onset dystonia parkinsonism and familial hemiplegic migraine type 2. We show a mapping of the isoform differences and the disease-related mutations on the recently determined crystal structure of the pig renal Na + ,K + -ATPase and a structural comparison to Ca 2+ -ATPase. Furthermore, we present new experimental data that address the role of a stretch of three conserved arginines near the C-terminus of the alpha subunit (Arg1003–Arg1005).